From time to time ASH will call on its members to reach out to Congress and state legislatures on issues of importance to hematologists and their patients. Below is a list of current issues of importance.
Urge Your Senators and Representative to Support the Cancer Drug Coverage Parity Act
Legislation has been reintroduced in the U.S. House of Representatives and U.S. Senate that would ensure that patients enrolled in certain federally regulated health plans have access and insurance coverage for all anti-cancer regimens. The Cancer Drug Coverage Parity Act would require any health plan that provides coverage for cancer chemotherapy treatment to provide coverage for orally administered and self-injectable anticancer medications at a cost no less favorable than the cost of IV, port administered, or injected anticancer medications.
Introduce Yourself and Hematology to the New Congress
Members of the 116th Congress, including 91 new Representatives and 9 new Senators, have been sworn into office and have already begun conducting legislative business. These newly elected officials – along with returning Senators and Representatives – need to know what hematology is and how federal programs impact research and patients.
ASH Legislative Victory! Thank Congress for Passing Sickle Cell Disease Legislation
For the past several years, ASH has met with congressional offices and called on members of the ASH Grassroots Network to take action in support of the Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (S. 2465). Because of your efforts and the work of ASH Grassroots Network advocates across the country, Congress is sending this important bill to President Trump to be signed into law.
Check back again for future updates on ASH’s State-Level Campaigns.
back to top